Physician profile
James B Macdougall
NPI 1235135823
$10,909.38
in general payments reported to CMS, 2019-2025
8 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $204 · 2022: $4,653 · 2023: $4,808 · 2024: $29.08 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,252 · Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,251.66 |
| Food and Beverage | $1,616.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovasis INC | $4,573.49 | 2022 | |
| Stryker Corporation | $3,220.18 | 2021-2025 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $2,695.90 | 2023-2025 | Rosa, Avenir, Persona |
| Depuy Synthes Sales INC. | $186.90 | 2019-2022 | |
| Spinal Elements, INC. | $93.08 | 2019 | |
| Globus Medical, INC. | $81.14 | 2021 | |
| Orthofix Medical, INC. | $43.89 | 2019 | |
| Kci USA, INC. | $14.80 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Macdougall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.